Skip to main content

Table 3 Drug therapy of newly-diagnosed dementia patients by the family practitioner

From: Effects of general practitioner training and family support services on the care of home-dwelling dementia patients - Results of a controlled cluster-randomized study

First diagnoses

A (n = 48)

B (n = 41)

C (n = 32)

p-value*

Adjusted p-value

   Prescription of specific anti-dementia drug (independent of guideline)§

14 (29.2%)

15 (36.6%)

12 (37.5%)

.6711

.857

First diagnoses with purely vascular dementia

A (n = 10)

B (n = 10)

C (n = 10)

  

   No cholinesterase inhibitor/Memantine in purely vascular dementia (in conformity with guideline)

4 (40.0%)

7 (70.0%)

9 (90.0%)

.0582

.071

First diagnoses with mild dementia with specific anti-dementia treatment

A (n = 11)

B (n = 12)

C (n = 9)

  

   No Memantine in mild dementia (in conformity with guideline)

6 (54.5%)

10 (83.3%)

6 (66.7%)

.3263

.477

  1. § cholinesterase inhibitor/Memantine
  2. * Chi²-Test
  3. 1 Chi² (2) = .797
  4. 2 Chi² (2) = 5.700
  5. 3 Chi² (2) = 2.239